The Use of Heliox in Obstructive Sleep Apnea Syndrome

• Status: Completed
• Trial end date: 2011-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The goals of the project is to evaluate the effects of Heliox therapy on obstructive sleep apnea syndrome (OSAS).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Northwell Health
• Collaborator: Staten Island University Hospital

Criteria

Inclusion Criteria:

• Adults 18 or older with obstructive sleep apnea syndrome (OSAS) presenting for CPAP titration.

Exclusion Criteria:

• Professional singers.

• Television or Radio hosts.

• Disk Jockeys.

• Subjects requiring oxygen therapy.

• Subjects younger than 18 year old.

• Pregnant women.

• Patients with chronic obstructive pulmonary disease (COPD) with forced expiratory volume 1 (FEV1) less than 50%.

• History of anatomic upper airway obstruction.

• Uncontrolled asthma.